asx announcements

ASX Announcements Archive 2010

16 Dec 2010

Securities Trading Policy

read more >>
15 Dec 2010

Substantial Holding Notice for Antisense Therapeutics Limited

read more >>
19 Nov 2010

Change of Directors Interest Notice

read more >>
18 Nov 2010

Open Briefing - VEGF Inhibitor Technology Patents

read more >>
18 Nov 2010

Circadian Technologies Limited Sale of Unmarketable Parcels Complete

read more >>
11 Nov 2010

2010 AGM Managing Director's Presentation

read more >>
11 Nov 2010

Results of Annual General Meeting 11 November 2010

read more >>
10 Nov 2010

Major US and European Patents Granted to Circadian

read more >>
14 Oct 2010

Open Briefing - CEO on FY11 LAM Diagnostic Partnership

read more >>
11 Oct 2010

Notice of Annual General Meeting and Explanatory Memorandum

read more >>
11 Oct 2010

2010 Annual Report

read more >>
05 Oct 2010

Finance News Network Video Interview with CEO (CIR)

read more >>
30 Sep 2010

Circadian partners with Cincinnati Childrens Hospital in U.S. to develop blood test diagnostic for potentially fatal lung disease

read more >>
17 Sep 2010

Circadian Technologies Limited to Offer Shareholder Sale Facility for Unmarketable Parcels

read more >>
09 Sep 2010

Open Briefing - CEO on FY11 Outlook and Strategic Focus

read more >>
06 Sep 2010

Circadian granted key strategic VEGF-D patent in USA for diagnostic applications

read more >>
25 Aug 2010

Change of Directors Interest Notice

read more >>
20 Aug 2010

Preliminary Final Report (Appendix 4E) Financial Year Ended 30 June 2010

read more >>
18 Aug 2010

Notice of Change of Interests of Substantial Holder

read more >>
18 Aug 2010

Notice of Change of Interests of Substantial Holder

read more >>
16 Aug 2010

New issue announcement, application for quotation of additional securities and agreement

read more >>
16 Aug 2010

Details of the issue or offer of securities

read more >>
03 Aug 2010

Australian Microcap Investment Conference Presentation

read more >>
30 Jul 2010

Shares to be released from escrow

read more >>
28 Jun 2010

Corporate Presentation

read more >>
14 May 2010

Change of Directors Interest Notice

read more >>
13 May 2010

Change of Directors Interest Notice

read more >>
13 May 2010

Change of Directors Interest Notice

read more >>
13 May 2010

Ms Susan Madden appointed Company Secretary of Circadian

read more >>
11 May 2010

Change of Directors Interest Notice

read more >>
04 May 2010

VGX-100 Inhibits Tumour Growth - Open Briefing with CEO & MD Robert Klupacs

read more >>
30 Apr 2010

Change of Directors Interest Notice

read more >>
17 Apr 2010

VGX-100, a novel therapeutic monoclonal antibody targeting VEGF-C that inhibits tumor growth

read more >>
15 Apr 2010

VGX-100 significantly inhibits tumour growth in animal cancer models

read more >>
15 Apr 2010

Ms Natalie Korchev to resign as CFO and Company Secretary

read more >>
06 Apr 2010

Circadian Newsletter - April 2010

read more >>
26 Mar 2010

Change in substantial holding

read more >>
24 Mar 2010

Corporate Presentation

read more >>
24 Mar 2010

Current Corporate Presentation

read more >>
17 Feb 2010

Half Year Results and Operational Achievements

read more >>
05 Feb 2010

Change in substantial holder

read more >>